(2S,5R)-(Pivaloyloxy)methyl 3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate 4,4-dioxide
98%
- Product Code: 96290
CAS:
69388-79-0
| Molecular Weight: | 347.38 g./mol | Molecular Formula: | C₁₄H₂₁NO₇S |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD00867003 | |
| Melting Point: | Boiling Point: | 537.53 °C at 760 mmHg (lit.) | |
| Density: | Storage Condition: | 2-8°C, dry |
Product Description:
This compound is primarily used as an intermediate in the synthesis of beta-lactam antibiotics, particularly penicillins and cephalosporins. Its structure is crucial for the development of prodrugs, which enhance the bioavailability and stability of active pharmaceutical ingredients. The compound is often employed in research and pharmaceutical manufacturing to improve the pharmacokinetic properties of antibiotics, ensuring better absorption and efficacy in therapeutic applications. Additionally, it plays a role in the development of novel antimicrobial agents to combat resistant bacterial strains.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | White to Off-White Solid |
| PURITY | 97.5-100 |
| Infrared spectrum | Conforms to Structure |
| NMR | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | ฿2,840.00 |
+
-
|
| 0.500 | 10-20 days | ฿8,960.00 |
+
-
|
(2S,5R)-(Pivaloyloxy)methyl 3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate 4,4-dioxide
This compound is primarily used as an intermediate in the synthesis of beta-lactam antibiotics, particularly penicillins and cephalosporins. Its structure is crucial for the development of prodrugs, which enhance the bioavailability and stability of active pharmaceutical ingredients. The compound is often employed in research and pharmaceutical manufacturing to improve the pharmacokinetic properties of antibiotics, ensuring better absorption and efficacy in therapeutic applications. Additionally, it plays a role in the development of novel antimicrobial agents to combat resistant bacterial strains.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :